Tandem Diabetes Care (TNDM) EBT (QoQ) (2013 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) EBT (QoQ) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.27 Bn | 811.05 Mn | 144.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.02% |
| Mar 31, 2026 | -520.90% |
| Dec 31, 2025 | 118.80% |
| Sep 30, 2025 | 56.44% |
| Jun 30, 2025 | 52.73% |
| Mar 31, 2025 | -407,100.00% |
| Dec 31, 2024 | 100.13% |
| Sep 30, 2024 | 23.97% |
| Jun 30, 2024 | 24.76% |
| Mar 31, 2024 | -26.25% |
| Dec 31, 2023 | -1.89% |
| Sep 30, 2023 | 11.26% |
| Jun 30, 2023 | 71.98% |
| Mar 31, 2023 | -667.03% |
| Dec 31, 2022 | 65.97% |
| Sep 30, 2022 | -264.22% |
| Jun 30, 2022 | 20.92% |
| Mar 31, 2022 | -248.09% |
| Dec 31, 2021 | 89.83% |
| Sep 30, 2021 | 42.63% |